| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V80500 | ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 sodium (CMP- 13C9,15N3) | ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 (sodium) Yes 13C (carbon 13) and 15N (nitrogen 15) labelled Sodium ((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate. | |
|
V80644 | (+)-Gallocatechin-13C3 | (+)-Gallocatechin-13C3 is a 13C (carbon 13)-labeled (+)-Gallocatechin. | |
|
V78675 | (-)-Erinacin A-d3 | (-)-Erinacin A-d3 is the deuterium labelled form of (-)-Erinacin A. | |
|
V65106 | (-)-Nebivolol-d4 hydrochloride | 2124271-48-1 | (-)-Nebivolol-d4 (HCl) is the deuterium labelled form of (-)-Nebivolol HCl. |
|
V62888 | (1-Bromoethyl)benzene-d3 | 23088-42-8 | (1-Bromoethyl)benzene-d3 is the deuterium labelled form of (1-Bromoethyl)benzene. |
|
V63136 | (1E,4Z,6E)-Curcumin-d6 | 1335198-02-1 | (1E,4Z,6E)-Curcumin-d6 is the deuterium labelled form of (1E,4Z,6E)-Curcumin. |
|
V81190 | (1R,3S,4R)-ent-Entecavir-13C2,15N (ent-Entecavir-13C2,15N) | (1R,3S,4R)-ent-Entecavir-13C2,15N is 13C (carbon 13) and 15N (nitrogen 15) labelled (1R,3S,4R)-ent-Entecavir. | |
|
V63589 | (2,4-Dihydroxyphenyl)(phenyl)methanone-d5 (Ultraviolet absorber UV-0-d5) | 91586-06-0 | (2,4-Dihydroxyphenyl)(phenyl)methanone-d5 is the deuterium labelled form of (2,4-Dihydroxyphenyl)(phenyl)methanone. |
|
V63072 | (2,6-Dichlorophenyl)acetic-2,2-d2 | 1219803-63-0 | (2,6-Dichlorophenyl)acetic-2,2-d2 is the deuterium labelled form of 2,6-Dichlorophenylacetic acid. |
|
V65085 | (2-Bromoethyl)benzene-d5 | 35845-64-8 | (2-Bromoethyl)benzene-d5 is the deuterium labelled form of β-Phenethyl bromide. |
|
V64728 | (2-Carboxyethyl)dimethylsulfonium-d6 chloride (s,s-Dimethyl-β-propionic acid thetine-d6) | 1246274-70-3 | (2-Carboxyethyl)dimethylsulfonium-d6 chloride is the deuterium labelled form of (2-Carboxyethyl)dimethylsulfonium chloride. |
|
V64978 | (2-Chlorophenyl)diphenyl-methanol-d5 | 1219802-30-8 | (2-Chlorophenyl)diphenyl-methanol-d5 is the deuterium labelled form of (2-Chlorophenyl)diphenylmethanol. |
|
V64703 | (2-Fluoro-4-biphenyl)acetic acid-d5 | 2733149-72-7 | (2-Fluoro-4-biphenyl)acetic acid-d5 is the deuterium labelled form of (2-Fluoro-4-biphenyl)acetic acid. |
|
V63351 | (2RS,4R,8R)-δ-Tocopherol-d4 (Mixture of Diastereomers) | 1292815-80-5 | (2RS,4R,8R)-δ-Tocopherol-d4 (Mixture of Diastereomers) is the deuterium labelled form of (2RS,4R,8R)-δ-Tocopherol (Mixture of Diastereomers). |
|
V64975 | (2S)-2-(Acetylamino)-N,4-dimethylpentanamide-d16 | 1276197-56-8 | (2S)-2-(Acetylamino)-N,4-dimethylpentanamide-d16 is the deuterium labelled form of (2S)-2-(Acetylamino)-N,4-dimethylpentanamide. |
|
V65026 | (2S)-Gemcitabine-13C,15N2 hydrochloride | 1262897-74-4 | (2S)-Gemcitabine-13C,15N2 (HCl) is 13C and 15 N labeled (2S)-Gemcitabine HCl. |
|
V80502 | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7 (L-threo-2,6-Diaminopimelic acid-13C7) | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7 (L-threo-2,6-Diaminopimelic acid-13C7) is 13C (carbon 13)-labeled (2S,6S)-2,6-diaminoheptanedioic acid. | |
|
V63359 | (3-Bromopyridin-2-yl)methanol-d2 | 2170188-53-9 | (3-Bromopyridin-2-yl)methanol-d2 is the deuterium labelled form of (3-Bromopyridin-2-yl)methanol. |
|
V63757 | (3-Nitrophenyl)methanol-d6 | 1219795-18-2 | (3-Nitrophenyl)methanol-d6 is the deuterium labelled form of (3-Nitrophenyl)methanol. |
|
V80065 | (3R,4S)-Paroxetine-d4 hydrochloride ((3R,4S)-Paroxetine hydrochloride-d4; (3R,4S)-BRL29060-d4 hydrochloride; (3R,4S)-BRL29060A-d4) | Paroxetine EP impurity D-d4 ( HCl) is (3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine (Paroxetine Impurity) Deuterated substances. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
